The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative (P) UGT1A1 genotype guided irinotecan (iri) dosing ‘gFOLFIRINOX’ for gastroesophageal adenocarcinoma (GEA).
 
Daniel V.T. Catenacci
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Taiho Pharmaceutical
Speakers' Bureau - Foundation Medicine; Genentech; Guardant Health; Lilly; Merck; Merck
 
Leah Chase
No Relationships to Disclose
 
Samantha Lomnicki
No Relationships to Disclose
 
Theodore Karrison
No Relationships to Disclose
 
Robert de Wilton Marsh
Consulting or Advisory Role - HERON
 
Murtuza M. Rampurwala
Stock and Other Ownership Interests - Glaxosmithkline
Honoraria - Medscape
Consulting or Advisory Role - Celgene; Heron
Travel, Accommodations, Expenses - Dava Oncology; Merck
 
Sunil Narula
No Relationships to Disclose
 
Lindsay Alpert
No Relationships to Disclose
 
Namrata Setia
No Relationships to Disclose
 
Shu-Yuan Xiao
No Relationships to Disclose
 
John Hart
No Relationships to Disclose
 
Uzma Siddiqui
No Relationships to Disclose
 
Chih-Yi Liao
No Relationships to Disclose
 
Blase N. Polite
Research Funding - Merck
Other Relationship - Gerson Lehrman Group
 
Hedy L. Kindler
Consulting or Advisory Role - Aldeyra Therapeutics; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; ERYTECH Pharma; Five Prime Therapeutics; ipsen; Kyowa Hakko Kirin; Merck; Paradox Therapeutics
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Inhibrx (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Polaris (Inst); Roche/Genentech (Inst); Verastem (Inst)
 
Kiran Turaga
No Relationships to Disclose
 
Vivek N. Prachand
Honoraria - Medtronic; W.L. Gore & Associates
Consulting or Advisory Role - Medtronic; W.L. Gore & Associates
Travel, Accommodations, Expenses - W.L. Gore & Associates
 
Kevin K. Roggin
Travel, Accommodations, Expenses - Intuitive Surgical
 
Mark K. Ferguson
No Relationships to Disclose
 
Mitchell C. Posner
Consulting or Advisory Role - Sirtex Medical